XML 78 R68.htm IDEA: XBRL DOCUMENT v3.21.1
INVESTMENTS - RELATED PARTIES (Details 1) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Fair value of derivative instruments issued by AVLP $ 678,769 $ (4,411)
Avalanche International Corp. [Member]    
Balance at January 1, 2021 16,807,861  
Investment in convertible promissory notes of AVLP 1,094,698  
Investment in convertible promissory note of Alzamend (50,000)  
Investment in promissory note of Ault & Company 2,500,000  
Investment in common stock of AVLP and Alzamend 3,046,016  
Investment in warrants of Alzamend 953,984  
Short term advance in Alzamend (750,000)  
Fair value of derivative instruments issued by AVLP 1,560,302  
Unrealized gain in derivative instruments of AVLP 2,969,170  
Unrealized loss in warrants of Alzamend (13,086)  
Unrealized gain in common stock of AVLP and Alzamend 166,662  
Accretion of discount 3,870  
Accrued Interest 745  
Balance at March 31, 2021 28,290,222  
Avalanche International Corp. [Member] | Warrants and Common Stock [Member]    
Balance at January 1, 2021 6,139,391  
Investment in convertible promissory notes of AVLP  
Investment in convertible promissory note of Alzamend  
Investment in promissory note of Ault & Company  
Investment in common stock of AVLP and Alzamend 3,046,016  
Investment in warrants of Alzamend 953,984  
Short term advance in Alzamend  
Fair value of derivative instruments issued by AVLP 1,560,302  
Unrealized gain in derivative instruments of AVLP 2,969,170  
Unrealized loss in warrants of Alzamend (13,086)  
Unrealized gain in common stock of AVLP and Alzamend 166,662  
Accretion of discount  
Accrued Interest  
Balance at March 31, 2021 14,822,439  
Avalanche International Corp. [Member] | Convertible Promissory Note [Member]    
Balance at January 1, 2021 10,668,470  
Investment in convertible promissory notes of AVLP 1,094,698  
Investment in convertible promissory note of Alzamend (50,000)  
Investment in promissory note of Ault & Company 2,500,000  
Investment in common stock of AVLP and Alzamend  
Investment in warrants of Alzamend  
Short term advance in Alzamend (750,000)  
Fair value of derivative instruments issued by AVLP  
Unrealized gain in derivative instruments of AVLP  
Unrealized loss in warrants of Alzamend  
Unrealized gain in common stock of AVLP and Alzamend  
Accretion of discount 3,870  
Accrued Interest 745  
Balance at March 31, 2021 $ 13,467,783